400 filings
Page 6 of 20
6-K
SPRC
SciSparc Ltd
12 Oct 22
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
9:05am
6-K
SPRC
SciSparc Ltd
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
SPRC
SciSparc Ltd
16 Sep 22
Report of Foreign Private Issuer
11:03am
6-K
SPRC
SciSparc Ltd
25 Aug 22
Results indicate significant decrease in cocaine craving in a sub-group that received the treatment
6:54am
6-K
SPRC
SciSparc Ltd
19 Aug 22
Scisparc Announces the Full Exercise of Pre-Funded Warrants
4:01pm
6-K
SPRC
SciSparc Ltd
16 Aug 22
SciSparc Signs a Non-Binding Letter of Intent to Acquire American Food Supplements and Cosmetics Brand in Approximately $20 Million Deal
6:30am
6-K
SPRC
SciSparc Ltd
12 Aug 22
SciSparc Issued Israeli Patent for its Core Technology for Treating Central Nervous Systems Disorders
4:05pm
6-K
SPRC
SciSparc Ltd
11 Aug 22
Current Report
4:05pm
6-K
SPRC
SciSparc Ltd
11 Aug 22
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:42am
6-K
SPRC
SciSparc Ltd
4 Aug 22
Report of Foreign Private Issuer
4:00pm
6-K
SPRC
SciSparc Ltd
2 Aug 22
SciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome
4:00pm
EFFECT
SPRC
SciSparc Ltd
21 Jul 22
Notice of effectiveness
12:15am
CORRESP
SPRC
SciSparc Ltd
18 Jul 22
Correspondence with SEC
12:00am
UPLOAD
SPRC
SciSparc Ltd
15 Jul 22
Letter from SEC
12:00am
F-3
SPRC
SciSparc Ltd
7 Jul 22
Shelf registration (foreign)
4:22pm
6-K
SPRC
SciSparc Ltd
7 Jul 22
Report of Foreign Private Issuer
4:00pm
6-K
SPRC
SciSparc Ltd
7 Jul 22
Report of Foreign Private Issuer
7:49am
6-K
SPRC
SciSparc Ltd
1 Jul 22
Current report (foreign)
4:00pm
6-K
SPRC
SciSparc Ltd
29 Jun 22
SciSparc Successfully Completed The Development of its Proprietary Drug Candidate SCI-110 for its Upcoming Phase IIb Study In Tourette Syndrome
8:36am
6-K
SPRC
SciSparc Ltd
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am